BioArctic receives Orphan Drug Designation for exidavnemab the US
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted ...
Technology Networks23h
Bioenergetic Age Could Be Key Indicator of Alzheimer’s Risk
A person’s “bioenergetic age”, or how youthfully their cells generate energy, might be a key indicator of whether they’re at ...
pharmaphorum14h
Eisai to buy "dementia ecosystem" partner EcoNaviSta
The Japanese pharma company – currently in the process of rolling out new amyloid-targeting Alzheimer's therapy Leqembi ...
Central Illinois Proud on MSN4h
Illinois House moves bill for Alzheimer’s treatment forward
A bill that could help Illinois residents access Alzheimer’s treatment is making its way through the House. House Bill 1360 ...
JCN Newswire11h
NaaS Teams Up with Xiaomi Auto - What It Means for the EV Charging Landscape
NaaS Technology (NASDAQ: NAAS) has recently announced its partnership with Xiaomi Auto to integrate its extensive EV charging network into Xiaomi’s smart vehicle ecosystem. This collaboration enables ...